FGFR3 translocations in bladder cancer: differential sensitivity to HSP90 inhibition based on drug metabolism.

Acquaviva, J, He, S, Zhang, C et al. (11 more authors) (2014) FGFR3 translocations in bladder cancer: differential sensitivity to HSP90 inhibition based on drug metabolism. Molecular Cancer Research, 12 (7). 1042 - 1054. ISSN 1541-7786

Abstract

Metadata

Authors/Creators:
  • Acquaviva, J
  • He, S
  • Zhang, C
  • Jimenez, JP
  • Nagai, M
  • Sang, J
  • Sequeira, M
  • Smith, DL
  • Ogawa, LS
  • Inoue, T
  • Tatsuta, N
  • Knowles, MA
  • Bates, RC
  • Proia, DA
Copyright, Publisher and Additional Information: © 2014 American Association for Cancer Research. This is an author produced version of a paper published in Molecular Cancer Research. Uploaded in accordance with the publisher's self-archiving policy.
Dates:
  • Published: July 2014
Institution: The University of Leeds
Academic Units: The University of Leeds > Faculty of Medicine and Health (Leeds) > Institute of Molecular Medicine (LIMM) (Leeds) > Section of Experimental Oncology (Leeds)
The University of Leeds > Faculty of Medicine and Health (Leeds) > School of Medicine (Leeds) > Leeds Institute of Cancer and Pathology (LICAP) > Section of Experimental Oncology (Leeds)
Depositing User: Symplectic Publications
Date Deposited: 20 Oct 2015 08:24
Last Modified: 26 Jan 2018 05:49
Published Version: http://dx.doi.org/10.1158/1541-7786.MCR-14-0004
Status: Published
Publisher: American Association for Cancer Research
Identification Number: https://doi.org/10.1158/1541-7786.MCR-14-0004
Related URLs:

Share / Export

Statistics